Cohort 1, n = 20 | Cohort 2, n = 32 | Cohort 3, n = 13 | |
---|---|---|---|
Significant improvement in CNS-related symptoms (%) | 75% (6/8) | 78.6% (11/14) | 83.3% (5/6) |
Moderate improvement in CNS-related symptoms | 25% (2/8) | 7.1% (1/14) | 16.7% (1/6) |
No improvement in CNS-related symptoms | 0 | 14.3% (2/14) | 0 |
Deterioration in CNS-related symptoms | 0 | 0 | 0 |